Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

PSA is best for detecting prostate cancer recurrence and evaluating treatment response.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Testosterone therapy increases bone density in older men with low testosterone levels.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

PSA can help diagnose high androgen levels in women.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Hair loss gene linked to prostate issues.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Finasteride effectively treats male hair loss, increasing length and thickness.

Saw palmetto supplements may modestly improve hair regrowth with few side effects, but more research is needed.